Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3053 (LINC03053), also known as AC092198.1, is a member of the long intergenic non-coding RNA (lincRNA) family. LincRNAs are autonomously transcribed RNA molecules greater than 200 nucleotides in length, located between protein-coding genes, and do not encode proteins[1][3][5]. They can have regulatory roles including chromatin remodeling, regulation of gene expression, and nuclear organization, but the specific functional role of LINC03053 has not been characterized in the literature to date[1][3][5]. To date, there is no evidence that LINC03053 is a therapeutic target, nor is there known interaction with drugs, nor established biomarker or safety data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3053 (LINC03053).